Aug 24, 2017 Last Updated 2:24 PM, Aug 23, 2017

Drug companies flock to supercharged T-cells in fight against autoimmune disease

Published in Head news
Read 52 times
Rate this item
(0 votes)

Heidi Ledford summarizes the current situation regarding the clinical use of immunomodulatory cytokines as possible treatments in autoimmune diseases.


Last modified on Tuesday, 08 August 2017 15:26
Login to post comments

Registered area

Thanks to the support of
merck serono biogen sanofi

Conferences & Courses

JNIInternational Brain Research Organization
Bringing Neuroscience to the World
JNIJournal of Neuroimmunology
Studies on all branches of neurosciences covering both research and clinical problems of neuroscientific interest.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy